Loading clinical trials...
Loading clinical trials...
Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy of 2LHERP® in Patients With Recurrent Orofacial Herpes Infections.
Conditions
Interventions
2LHERP®
Placebo
Locations
6
Belgium
Private Practice
Beerzel, Belgium
Cabinet privé
Beuzet, Belgium
Clinique Saint-Luc (Bouge)
Bouge, Belgium
Private Practice
Linkebeek, Belgium
Cabinet privé
Noirefontaine, Belgium
Private Practice
Oisquercq, Belgium
Start Date
March 10, 2020
Primary Completion Date
March 31, 2027
Completion Date
March 31, 2027
Last Updated
October 31, 2024
NCT05429346
NCT03282916
NCT05226949
NCT03626376
NCT00000635
NCT03090802
Lead Sponsor
Labo'Life
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions